These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 15573254
1. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers. Chuang SC, Lee KT, Tsai KB, Sheen PC, Nagai E, Mizumoto K, Tanaka M. World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254 [Abstract] [Full Text] [Related]
2. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Cancer; 2001 Apr 01; 91(7):1332-41. PubMed ID: 11283934 [Abstract] [Full Text] [Related]
3. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Teh M, Wee A, Raju GC. Cancer; 1994 Sep 01; 74(5):1542-5. PubMed ID: 7520348 [Abstract] [Full Text] [Related]
4. The relationship between loss expression of DPC4/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma. Tang ZH, Zou SQ, Hao YH, Wang BJ, Yang XP, Chen QQ, Qiu FZ. Hepatobiliary Pancreat Dis Int; 2002 Nov 01; 1(4):624-9. PubMed ID: 14607700 [Abstract] [Full Text] [Related]
5. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Hoang MP, Murakata LA, Katabi N, Henson DE, Albores-Saavedra J. Mod Pathol; 2002 Dec 01; 15(12):1251-8. PubMed ID: 12481004 [Abstract] [Full Text] [Related]
6. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Caca K, Feisthammel J, Klee K, Tannapfel A, Witzigmann H, Wittekind C, Mössner J, Berr F. Int J Cancer; 2002 Feb 01; 97(4):481-8. PubMed ID: 11802210 [Abstract] [Full Text] [Related]
7. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W. Hum Pathol; 2010 Nov 01; 41(11):1558-65. PubMed ID: 20621328 [Abstract] [Full Text] [Related]
13. Frequency of loss expression of the DPC4 protein in various locations of biliary tract carcinoma. Tang Z, Zou S, Hao Y, Wang B, Yang X, Qiu F. Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec 01; 36(7):481-4. PubMed ID: 12411149 [Abstract] [Full Text] [Related]
14. Regulators of apoptosis in cholangiocarcinoma. Jhala NC, Vickers SM, Argani P, McDonald JM. Arch Pathol Lab Med; 2005 Apr 01; 129(4):481-6. PubMed ID: 15794670 [Abstract] [Full Text] [Related]
18. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Kang YK, Kim WH, Jang JJ. Hum Pathol; 2002 Sep 01; 33(9):877-83. PubMed ID: 12378511 [Abstract] [Full Text] [Related]
19. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. Sung JY, Kim GY, Lim SJ, Park YK, Kim YW. Pathol Res Pract; 2010 Jan 15; 206(1):24-9. PubMed ID: 19819644 [Abstract] [Full Text] [Related]
20. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A. Hepatology; 1995 Sep 15; 22(3):774-9. PubMed ID: 7657282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]